Theory Financial LLC Pfizer Inc Transaction History

Theory Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$36.12 - $41.79 $9,752 - $11,283	-270 Reduced 4.51%	5,721 $209,000
Q4 2022 Feb 07, 2023	SELL	$41.75 - $54.5 $11,773 - $15,369	-282 Reduced 4.5%	5,991 $307,000
Q2 2022 Aug 10, 2022	BUY	$46.53 - $55.17 $16,518 - $19,585	355 Added 6.0%	6,273 $324,000
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $244,531 - $362,477	5,918 New	5,918 $349,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Theory Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Theory Financial LLC with notifications on news.